Long-term safety of unopposed estrogen used by women surviving myocardial infarction : 14 year follow-up of the ESPRIT randomised controlled trial

View/Open
Esprit_NC_final_for_BJOG_re_submission_.doc (114.5Kb)
Publication date
05/2014
Author
Metadata
Show full item record
Citation
Cherry , N , McNamee , R , Heagerty , A , Kitchener , H & Hannaford , P 2014 , ' Long-term safety of unopposed estrogen used by women surviving myocardial infarction : 14 year follow-up of the ESPRIT randomised controlled trial ' , BJOG-An International Journal of Obstetrics and Gynaecology , vol. 121 , no. 6 , pp. 700-705 . https://doi.org/10.1111/1471-0528.12598
URI
http://hdl.handle.net/2164/4478
DOI
https://doi.org/10.1111/1471-0528.12598
Rights
This is the accepted version of the following article:Cherry, N, McNamee, R, Heagerty, A, Kitchener, H & Hannaford, P 2014, 'Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14 year follow-up of the ESPRIT randomised controlled trial' BJOG-An International Journal of Obstetrics and Gynaecology, vol 121, no. 6, pp. 700-705., which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.12598/abstract
Collections